Products, Technologies, Markets and Opportunities in Diabetes Management Worldwide, 2009-2018 (#D510)

280 pages   · 67 Exhibits   · 123 Company Profiles   · July 2010
Report #D510


This report details the worldwide incidence and prevalence by country/region of Type 1 and Type 2 diabetes and details the current and projected market for diagnostic and therapeutic products in the management of diabetes, including anti-diabetic drugs, alternative insulin types, blood glucose monitoring (including continuous monitoring devices), insulin pumps, and other established and emerging products in diabetes management.  The report provides an emphasis of detail on the status of development of novel products including noninvasive monitoring, oral/inhaled/other insulin delivery. The report details the clinical and technology developments underlying this huge and evolving worldwide market, with data on products in development and on the market; market size and forecast; competitor market shares; competitor profiles; and market opportunity.

[See coverage of diabetes in the advanced medical technologies blog.]

Separate size, growth and competitor share data are presented for the U.S., European, Asia/Pacific and Rest of World.  The report profiles active companies including detailed profile information on major competitors, brief profiles of companies with less sizeable current or potential positions in the market, plus additional profiles of companies with novel or advanced research activities in the market.

The report establishes the current worldwide market size for major technology segments as a baseline for and projecting growth in the market over a ten-year forecast. The report also assesses and projects the composition of the market as technologies gain or lose relative market performance over this period.

Products & Technologies Covered:

  • Oral hypoglycemic drugs
  • Insulin by type
  • Blood glucose monitors
  • Lancets
  • Blood sampling devices
  • HbA1c testing
  • Insulin pumps
  • Insulin syringes
  • Inhaled insulin
  • Artificial pancreas
  • Pancreatic transplant
  • Islet cell transplants
  • Stem cell
  • Antibody treatment
  • Vaccines
  • Genetic approaches
  • Novel drugs
  • Continuous glucose monitoring

See the table of contents and list of exhibits at link.